SUNHERE(300452) 证券时报网·2025-03-19 08:49Group 1 - The core viewpoint of the news is the groundbreaking ceremony for the R&D center and production base of Shanhe Pharmaceutical Excipients, which will enhance the company's R&D capabilities and optimize its product structure, contributing to its strategic layout in the high-end pharmaceutical excipients market [1] - The project covers an area of 13,061 square meters with a construction area of 37,500 square meters and a construction period of 2 years, aiming to add an annual production capacity of 1,000 tons of composite excipients [1] - The company is currently a leader in the domestic solid dosage pharmaceutical excipients industry, with increasing market share in health products and plant capsules, and is accelerating the R&D and industrialization of new fields such as injectable excipients and premixed excipients [2] Group 2 - Several products, including microcrystalline cellulose, magnesium stearate, sodium carboxymethyl starch, hydroxypropyl methylcellulose, and cross-linked sodium carboxymethyl cellulose, have leading production and sales levels in China, with multiple products recognized as high-tech products in Anhui Province [2] - The company has developed 48 products that have obtained drug excipient registration numbers from the CDE, and has received food production licenses for several products, making it one of the domestic pharmaceutical excipients manufacturers with a wide range of specialized and series products [3]